| Dr Uzochukwu Amadi, MD | |
|
9850 W St Lukes Dr, Nampa, ID 83687-7912 | |
| (208) 205-7282 | |
| (208) 205-7591 |
| Full Name | Dr Uzochukwu Amadi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 9850 W St Lukes Dr, Nampa, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689961088 | NPI | - | NPPES |
| 300019600 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 2011019834 (Missouri) | Secondary |
| 207R00000X | Internal Medicine | 01080817A (Indiana) | Secondary |
| 207R00000X | Internal Medicine | M-16506 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Hancock Regional Hospital | Greenfield, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hancock Physician Network, Llc | 8325952633 | 107 |
| Hospitalist Physicians Of Indiana Pc | 1052795986 | 163 |
| University Family Physicians, Inc. | 7911992797 | 424 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
| Entity Name | Hancock Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806470 PECOS PAC ID: 8325952633 Enrollment ID: O20040130000777 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
| Entity Name | University Family Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043275787 PECOS PAC ID: 7911992797 Enrollment ID: O20040420000393 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
| Entity Name | Sound Physicians Of Indiana, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528311149 PECOS PAC ID: 4981841780 Enrollment ID: O20130515000624 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720416555 PECOS PAC ID: 7719119965 Enrollment ID: O20140422001842 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
| Entity Name | Hospitalist Physicians Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306576277 PECOS PAC ID: 1052795986 Enrollment ID: O20220826000967 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Uzochukwu Amadi, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Dr Uzochukwu Amadi, MD 9850 W St Lukes Dr, Nampa, ID 83687-7912 Ph: (208) 205-7282 |
News Archive
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.
A study published today in the Journal of the American Medical Association (JAMA) indicated that many Hispanic/Latino adults living in the United States are at high risk for heart attack or stroke. This risk is highest in men and in older people, born in the US or that have lived in the US more than 10 years, that prefer to speak English, are lower income, or never finished high school.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Researchers funded by the National Science Foundation (NSF) and affiliated with the Salk Institute in San Diego, Calif., have succeeded in converting chalcone synthase, a biosynthetic protein enzyme found in all higher plants, into an efficient resveratrol synthase.
In one of the first published studies using data from the Health eHeart Study, UCSF researchers have found that people are divided on the cardiovascular benefits of alcohol consumption. And, those who do perceive alcohol as "heart healthy" drink substantially more than their counterparts.
› Verified 1 days ago
Wesley David Pidcock, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4400 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-2100 Fax: 208-302-2125 | |
Kenneth Wilhelm Jr., Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4400 E Flamingo Ave, Nampa, ID 83687 Phone: 208-288-4970 Fax: 208-288-4990 | |
Michael M Dee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-463-3234 Fax: 208-463-3044 | |
Justin Tomal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Garrity Blvd, Nampa, ID 83687 Phone: 208-343-6458 | |
Braden Lawrence, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 85 S Middleton Rd, Nampa, ID 83651 Phone: 208-381-4100 | |
Patricia M Buersmeyer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9850 W St Lukes Dr, Nampa, ID 83687 Phone: 208-468-5920 | |
Ryan J. Williams, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 N Happy Valley Rd, Nampa, ID 83687 Phone: 208-401-9639 |